Stereochemistry in clinical medicine: A neurological perspective

Journal of Clinical Neuroscience

Volumn 10, Issue 6, 2003, Pages 649-654

  Cordato, D J ^a   Mather, L E ^c   Herkes, G K ^b  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c NONE

Author keywords

Chirality; Enantiomers; Stereoisomers

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; APOMORPHINE; BARBITURIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; CLOPIDOGREL; DICLOFENAC; ENTACAPONE; ETHOSUXIMIDE; ETIRACETAM; HEXOBARBITAL; IBUPROFEN; INDOMETACIN; KETOROLAC; LEVODOPA; METHYLPHENOBARBITAL; NAPROXEN; OXCARBAZEPINE; PENTOBARBITAL; PHENOBARBITAL; PLASMA PROTEIN; REMACEMIDE; RIVASTIGMINE; SECOBARBITAL; SELEGILINE; THIAMYLAL; THIOPENTAL; TIAGABINE; UNINDEXED DRUG; VIGABATRIN;

CHIRALITY; CLINICAL MEDICINE; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MANUFACTURE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENANTIOMER; EPILEPTIC STATE; KIDNEY CLEARANCE; NEUROLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; RACEMIC MIXTURE; REVIEW; STEREOCHEMISTRY; STEREOISOMERISM;

EID: 0242390952     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2002.10.001     Document Type: Review

References (40)

1. Mather LE, Rutten AJ. Stereochemistry and its relevance in anaesthesiology. Curr Opin Anaesthesiol 1991; 4: 473-479.
2. Hutt AJ, Tan SC. Drug chirality and its clinical significance. Drugs 1996; 52(Suppl 5): 1-12.
3. Crom WR. Effect of chirality on pharmacokinetics and pharmacodynamics. Am J Hosp Pharm 1992; 49(Suppl 1): S9-S14.
4. Ariens EJ. Stereochemistry: a source of problems in medicinal chemistry. Med Res Rev 1986; 6: 451-466.
5. Calvey TN. Isomerism an anaesthetic drugs. Acta Anaesthesiol Scand 1995; 39(Suppl 106): 83-90.
6. Wainer IW, Marcotte AA. Stereochemical terms and concepts. An overview. In: Wainer IW (ed) Drug Stereochemistry Analytical Methods and Pharmacology. second edn. Marcel Dekker, New York 1993; 25-34.
7. Mather LE, Edwards. Chirality in anaesthesia - ropivacaine, ketamine and thiopentone. Curr Opin Anaesthesiol 1998; 11: 383-390.
8. Drayer DE. The early history of stereochemistry. From the discovery of molecular asymmetry and the first resolution of a racemate by Pasteur to the asymmetrical chiral carbon of van't Hoff and Le Bel. In: Wainer IW (ed) Drug Stereochemistry Analytical Methods and Pharmacology. second ed. Marcel Dekker, New York 1993; 1-24.
9. Aronson J. When I use a word ...: Grapes. BMJ 1998; 317: 688-689.
10. Cahn RS, Ingold CK, Prelog V. The specification of asymmetric configuration in organic chemistry. Experientia 1956; 1: 81-124.
11. Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of Parkinsonism. NEJM 1967; 276: 374-379.
12. Cotzias GC, Papavasiliou PS, Gallene R. Modification of Parkinsonism - chronic treatment with L-Dopa. NEJM 1969; 280: 337-345.
13. Reynolds GP, Elsworth JD, Blau K, Sandler M, Lees AJ, Stern GM. Deprenyl is metabolized to methamphetamine and amphetamine in man. Br J Clin Pharmacol 1978; 6: 542-544.
14. Grunblatt E, Mandel S, Maor G, Youdim MB. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss. J Neurochem 2001; 77: 146-156.
15. Keranen T, Gordin A, Karlsson M, Korpela K, Pentikainen PJ et al. Inhibition of soluble catechol-O-methyltransferase and single dose pharmacokinetics after oral and intravenous administration of entacapone. Eur J Clin Pharmacol 1994; 46: 151-157.
16. Andrews PR, Mark LC. Structural specificity of barbiturates and related drugs. Anesthesiology 1982; 57: 314-320.
17. Nguyen KT, Stephens DP, McLeish MJ, Crankshaw DP, Morgan DJ. Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental. Anesth Analg 1996; 83: 552-558.
18. Cordato DJ, Gross AS, Herkes GK, Mather LE. Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac-thiopentone. Br J Clin Pharmacol 1997; 43: 355-362.
19. Cordato DJ, Mather LE, Gross AS, Herkes GK. Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy. Anesthesiology 1999; 91: 1693-1702.
20. A receptor. Br J Pharmacol 1999; 128: 77-82.
21. Flesch G, Francotte E, Hell F, Degen PH. Determination of the R-(-)- and S-(+)-enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma by enantioselective high-performance liquid chromatography. J Chromatogr A 1992; 581: 147-151.
22. McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldmann KF. Oxcarbazepine: mechanisms of action. Epilepsia 1994; 35(Suppl 3): S5-S9.
23. Volosov A, Xiaodong S, Perucca E, Yagen B, Sintov A, Bialer M. Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clin Pharmacol Therap 1999; 66: 547-553.
24. Sheean G, Schramm T, Anderson DS, Eadie MJ. Vigabatrin-plasma enantiomer concentrations and clinical effects. Clin Exp Neurol 1992; 29: 107-116.
25. Harden CL. New antiepileptic drugs. Neurology 1994; 44: 787-795.
26. Patsalos PN, Duncan JS. New antiepileptic drugs. A review of their current status and clinical potential. CNS Drugs 1994; 2: 40-77.
27. Mifsud J, Collier PS, Millership JS. The pharmacokinetics of ethosuximide enantiomers in the rat. Biopharm Drug Dispos 2001; 22: 83-89.
28. Adkins JC, Noble S. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Drugs 1998; 55: 437-460.
29. Hutt AJ, Caldwell J. The metabolic chiral inversion of 2-arylproprionic acids - a novel route with pharmacological consequences. J Pharm Pharm 1983; 35: 693-704.
30. Wechter WJ. Drug chirality: on the mechanism of R-aryl proprionic acid class NSAIDs. Epimerization in humans and the clinical implications for the use of racemates. J Clin Pharmacol 1994; 34: 1036-1042.
31. Rudy AC, Knight PM, Brater DC, Hall SD. Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment. J Pharmacol Exp Ther 1995; 273: 88-93.
32. McGurk M, Robinson P, Rajayogeswaran V, De Luca M, Casini A, Artigas R, Munoz G, Mauleon D. Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain. J Clin Pharmacol 1998; 38(Suppl 12): 46S-54S.
33. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000; 60: 139-176.
34. Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 1987; 37: 1725-1728.
35. Longstreth JA, Verapamil. A chiral challenge to the pharmacokinetic and pharmacodynamic assessment of bioavailability and bioequivalence. In: Wainer IW (ed) Drug Stereochemistry Analytical Methods and Pharmacology. Second ed. Marcel Dekker, New York 1993; 315-336.
36. Takahashi H, Echizen H. Pharmacogenetics of warfarin and its clinical implications. Clin Pharmcokinet 2001; 40: 587-603.
37. Yamazaki H, Shimada T. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Biochem Pharmacol 1997; 54: 1195-1203.
38. Bar-On P, Millard CB, Harel M, Dvir H, Enz A, Sussman JL et al. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry 2002; 41: 3555-3564.
39. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
40. Tucker GT. Chiral switches. Lancet 2000; 355(9209): 1085-1087.